We considered the following 12 variables as potentially associated with anticoagulant outcome: course of disease (p = 0.034), time from onset to anticoagulation (p = 0.548), alanine aminotransferase (ALT, p = 0.017), aspartate aminotransferase (AST, p = 0.001), TB (p < 0.001), albumin (ALB, p = 0.261), Scr (p = 0.021), prothrombin time (PT, p < 0.001), FIB (p = 0.02), D2 polymers (D2, p < 0.001), peak PVV (p < 0.001), and portal vein thrombosis (PVT, p = 0.578). The gene discussed is GPT; the disease is Portal vein thrombosis.